课题基金 / 基金详情

SERUM AND CSF DRUG LEVELS AND D2 OCCUPANCY FOR PALIPERIDONE AND RISPERIDONE

SERUM AND CSF DRUG LEVELS AND D2 OCCUPANCY FOR PALIPERIDONE AND RISPERIDONE
帕利哌酮和利培酮的血清和脑脊液药物水平以及 D2 占用率
批准号:
7958245
负责人:
Emil CHRIS MULY
金额:
$5.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2010-04-30

项目摘要

项目成果

Emil CHRIS MULY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Antagonism of the D2 family of dopamine receptors is critical for antipsychotic action and occupancy of central D2 receptors has been related a threshold for antipsychotic effect, as well as a threshold for extrapyramidal side effects (EPS). However, previous studies did not perform baseline measurements of D2 binding potential (Bmax) in the same cohort of patients, but rather relied on an age corrected estimate from a separate, mixed group of healthy subjects and drug na¿ve patients. We have completed our study of the relationship between dose, serum level and cerebrospinal fluid level in monkeys and are analyzing the results. We have completed our study of the central D2 occupancy of drug at different doses using serial PET scans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REGIONAL VARIATION IN D1 SIGNALING PROTEIN LOCALIZATION
  • 批准号:
    8357443
  • 项目类别:
  • 资助金额:
    $3.29万
  • 财政年份:
    2011
  • 负责人:
    Emil CHRIS MULY
  • 依托单位:
SERUM AND CSF DRUG LEVELS AND D2 OCCUPANCY FOR PALIPERIDONE AND RISPERIDONE
  • 批准号:
    8357465
  • 项目类别:
  • 资助金额:
    $4.12万
  • 财政年份:
    2011
  • 负责人:
    Emil CHRIS MULY
  • 依托单位:
REGIONAL VARIATION IN D1 SIGNALING PROTEIN LOCALIZATION
  • 批准号:
    8172389
  • 项目类别:
  • 资助金额:
    $4.39万
  • 财政年份:
    2010
  • 负责人:
    Emil CHRIS MULY
  • 依托单位:
SERUM AND CSF DRUG LEVELS AND D2 OCCUPANCY FOR PALIPERIDONE AND RISPERIDONE
  • 批准号:
    8172419
  • 项目类别:
  • 资助金额:
    $5.48万
  • 财政年份:
    2010
  • 负责人:
    Emil CHRIS MULY
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: